Mammatyper is designed specifically to measure these 4 biomarkers
The 17th St Gallen International breast cancer Conference (2021) Expert Panel recommends the use of four biomarkers for molecular subtyping of breast cancer:
These markers, in turn, are used to
identify 5 distinct breast cancer
Each of these subtypes is associated with a clear therapy recommendation and distinct characteristics of the patient’s prognosis.